NK activity in patients with pathological hyperprolactinemia: effect of bromocriptine.
Honorati
M C
MC
Institute of Internal Medicine, Infectious Diseases and Immunopathology, University of Milan, Italy.
Travaglini
P
P
De Bernardi
B
B
Scorza
R
R
Hu
C
C
Togni
M E
ME
Radelli
L
L
Vanoli
M
M
Zanussi
C
C
D000328:Adult; D001971:Bromocriptine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology*; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000188:drug therapy / Q000276:immunology*; D011388:Prolactin / Q000097:blood*; D015175:Prolactinoma / Q000188:drug therapy / Q000276:immunology*; D012016:Reference Values
D001971:Bromocriptine; D011388:Prolactin